tiprankstipranks
Trending News
More News >
Celadon Pharmaceuticals PLC (GB:CEL)
LSE:CEL
UK Market

Celadon Pharmaceuticals PLC (CEL) Stock Statistics & Valuation Metrics

Compare
15 Followers

Total Valuation

Celadon Pharmaceuticals PLC has a market cap or net worth of £9.23M. The enterprise value is 28.51M.
Market Cap£9.23M
Enterprise Value28.51M

Share Statistics

Celadon Pharmaceuticals PLC has 68,845,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,845,810
Owned by Insiders
Owned by Institutions

Financial Efficiency

Celadon Pharmaceuticals PLC’s return on equity (ROE) is -2.26 and return on invested capital (ROIC) is -68.65%.
Return on Equity (ROE)-2.26
Return on Assets (ROA)-0.77
Return on Invested Capital (ROIC)-68.65%
Return on Capital Employed (ROCE)-0.72
Revenue Per Employee2.78K
Profits Per Employee-264.44K
Employee Count27
Asset Turnover<0.01
Inventory Turnover0.74

Valuation Ratios

The current PE Ratio of Celadon Pharmaceuticals PLC is -9.97. Celadon Pharmaceuticals PLC’s PEG ratio is 0.03.
PE Ratio-9.97
PS Ratio0.00
PB Ratio3.77
Price to Fair Value22.54
Price to FCF-3.53
Price to Operating Cash Flow-4.74
PEG Ratio0.03

Income Statement

In the last 12 months, Celadon Pharmaceuticals PLC had revenue of 75.00K and earned -7.14M in profits. Earnings per share was -0.12.
Revenue75.00K
Gross Profit1.00K
Operating Income-5.93M
Pretax Income-7.52M
Net Income-7.14M
EBITDA-6.39M
Earnings Per Share (EPS)-0.12

Cash Flow

In the last 12 months, operating cash flow was -5.55M and capital expenditures -192.00K, giving a free cash flow of -5.74M billion.
Operating Cash Flow-5.55M
Free Cash Flow-5.74M
Free Cash Flow per Share-0.08

Dividends & Yields

Celadon Pharmaceuticals PLC pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.76
52-Week Price Change-79.70%
50-Day Moving Average9.17
200-Day Moving Average16.35
Relative Strength Index (RSI)64.22
Average Volume (3m)94.10K

Important Dates

Celadon Pharmaceuticals PLC upcoming earnings date is Sep 25, 2025, Before Open (Not Confirmed).
Last Earnings DateApr 25, 2025
Next Earnings DateSep 25, 2025
Ex-Dividend Date

Financial Position

Celadon Pharmaceuticals PLC as a current ratio of 2.62, with Debt / Equity ratio of 60.35%
Current Ratio2.62
Quick Ratio2.51
Debt to Market Cap<0.01
Net Debt to EBITDA-0.54
Interest Coverage Ratio-9.92

Taxes

In the past 12 months, Celadon Pharmaceuticals PLC has paid -261.00K in taxes.
Income Tax-261.00K
Effective Tax Rate0.03

Enterprise Valuation

Celadon Pharmaceuticals PLC EV to EBITDA ratio is -11.68, with an EV/FCF ratio of -11.82.
EV to Sales995.15
EV to EBITDA-11.68
EV to Free Cash Flow-11.82
EV to Operating Cash Flow-12.50

Balance Sheet

Celadon Pharmaceuticals PLC has £16.00K in cash and marketable securities with £4.78M in debt, giving a net cash position of £4.76M billion.
Cash & Marketable Securities£16.00K
Total Debt£4.78M
Net Cash£4.76M
Net Cash Per Share£0.07
Tangible Book Value Per Share£0.05

Margins

Gross margin is -275.00%, with operating margin of -7908.00%, and net profit margin of -9520.00%.
Gross Margin-275.00%
Operating Margin-7908.00%
Pretax Margin-10030.67%
Net Profit Margin-9520.00%
EBITDA Margin-8521.33%
EBIT Margin-9233.33%

Analyst Forecast

The average price target for Celadon Pharmaceuticals PLC is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis